Navigation Links
NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation
Date:5/21/2013

MOUNT PROSPECT, Ill., May 21, 2013 /PRNewswire-USNewswire/ -- Reaching a critical milestone in the generic Top-Level Domain (gTLD) approval process, the National Association of Boards of Pharmacy® (NABP®) application to own and operate the .PHARMACY domain suffix has passed the Internet Corporation for Assigned Names and Numbers (ICANN) initial evaluation. NABP intends to launch the .PHARMACY gTLD by the end of 2013, and will make the new domain available to legitimate online pharmacies and related entities that are located in the United States as well as in other countries. Passing ICANN's initial evaluation is a key success in realizing the Association's vision – established in partnership with a global coalition of stakeholders – of creating a secure and trustworthy online space for pharmacy, benefiting consumers around the world.

Having reached this key point, NABP will now work toward operationalizing the .PHARMACY gTLD program, as it awaits the final stages of ICANN's evaluation process. Next steps in the process include execution of the registry agreement with ICANN and performance of pre-delegation testing, which ensures that NABP and its technical partners have the capacity to operate the new .PHARMACY gTLD in a stable and secure manner.  

"Passing this hurdle in the .PHARMACY application process is a significant success in NABP's initiative to establish a safe online space that will benefit patients and the health care community around the world. With the online distribution of counterfeit and substandard medications posing a growing threat to consumers, NABP is extremely pleased to move forward with its plans for the .PHARMACY gTLD," states NABP President Karen M. Ryle , MS, RPh. "By distinguishing .PHARMACY as a domain space exclusively for appropriately licensed, legitimate Internet pharmacies operating in compliance with international pharmacy standards, NABP aims to protect the global public health from dangers of substandard drugs distributed by rogue online sellers."

With the support of a global coalition of stakeholders, including international pharmacy organizations, regulators, industry experts, and law enforcement agencies, NABP applied to ICANN in June 2012 to own and operate the .PHARMACY gTLD. This global coalition shares the Association's concern about illegal online drug sellers distributing products that endanger patient health worldwide. Thus, in its application, NABP stated the importance of ensuring that only legitimate Web site operators that adhere to pharmacy laws in the jurisdictions in which they are based and to which they sell medicine will be able to register domain names in .PHARMACY.  

NABP continues to monitor Web sites selling prescription drugs to patients in the U.S. and as of April 2013, has reviewed over 10,400 Internet drug outlets and found 97% of them to be out of compliance with pharmacy laws and practice standards established in the US to protect the public health. Of these 10,082 Web sites identified as Not Recommended, nearly half offer foreign or non-Food and Drug Administration-approved drugs to US residents, and many of these distribute dangerous counterfeits to unsuspecting consumers. Further, health and regulatory agencies in the US and abroad have reported cases of patients harmed by counterfeit, substandard, and adulterated medications distributed by illegal Internet sellers.

The .PHARMACY application was submitted as part of ICANN's expansion of available gTLDs, which currently include familiar suffixes such as .edu, .gov, and .com. Stakeholders that support NABP's application include many groups in the global pharmacy community. Among the coalition of stakeholders behind this initiative are the Alliance for Safe Online Pharmacies, Eli Lilly and Company, European Alliance for Access to Safe Medicines, Gilead Sciences, Inc, International Pharmaceutical Federation, INTERPOL, Janssen Pharmaceuticals, Inc, LegitScript, Merck/MSD, National Association of Pharmacy Regulatory Authorities, and state boards of pharmacy.

For more information about NABP and the .PHARMACY application, visit www.nabp.net/programs/pharmacy/pharmacy-and-nabp.

NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health.


'/>"/>
SOURCE National Association of Boards of Pharmacy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NABP Applies for New .PHARMACY Generic Top-Level Domain to Provide a Secure Destination for Consumers
2. Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal
3. 3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders
4. Simcere Pharmaceutical Group Announces Receipt of "Going Private" Proposal
5. Royalty Pharma Announces Proposal To Acquire Elan
6. 3SBio Independent Committee Selects Legal Counsel in connection with Going Private Proposal
7. 3SBio Inc. Announces Receipt of "Going Private" Proposal at $15 Per ADS
8. ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS
9. iBio Passes Commercial Technology Transfer Milestone
10. John Velyvis MD Surpasses 550 Robotic Assisted Partial Knee Resurfacing Procedures
11. Mobile MIM for Diagnostic Imaging Surpasses 250,000 Downloads
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 Worldwide ... achieve significant growth as next generation systems provide ... use radiology for cancer surgery. New systems pinpoint ... overdosing that has been such a problem previously, ... delivered. Radiosurgery robots take cancer surgery far beyond ...
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... and competitive market to drive long-term market growth ... very common set of chronic disorders that affect ... disparate in terms of their symptoms and key ... by dysregulation of immune pathways and an inappropriate ...
Breaking Medicine Technology:
(Date:2/5/2016)... New York (PRWEB) , ... February 05, 2016 , ... ... use and find themselves having to wait longer to access the treadmills. It’s a ... New Year’s resolutions to lose weight and get in shape by joining gyms, starting ...
(Date:2/5/2016)... ... , ... At its annual meeting held last week, the American Parkinson Disease ... of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We are pleased ... APDA President and CEO. “Pat has tirelessly served APDA since 2001 when he was ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Colorize ... on one drop zone to the next using Colorize's dynamic moving camera. Colorize is ... This package includes a 3D slideshow environment with 1 to 5 focus points per ...
(Date:2/5/2016)... ... 05, 2016 , ... On June 9-10, Las Vegas will ... education (CME) event presented by the Association for Comprehensive Care in Rare Diseases ... whose mission is to provide education, tools, and resources to primary care clinicians ...
(Date:2/5/2016)... Luis Obispo, CA (PRWEB) , ... February 05, 2016 , ... ... new changes that Medicare San Luis Obispo users can expect to see in 2016. ... , The two most significant changes will directly impact many San Luis Obispo seniors ...
Breaking Medicine News(10 mins):